EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies

Jameel M Al-Khayri, Mamtha Ravindran, Akshatha Banadka, Chendanda Devaiah Vandana, Kushalva Priya, Praveen Nagella, Kowshik Kukkemane

Pharmaceuticals · 18.10.2024 · 17 (10) · 1391

DOI: 10.3390/ph17101391 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 18.10.2024. Verfasst von Jameel M Al-Khayri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agricultural Biotechnology, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, King Faisal University, King Faisal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disorder marked by the gradual loss of motor neurons, leading to significant disability and eventual death. Despite ongoing research, there are still limited treatment options, underscoring the need for a deeper understanding of the disease’s complex mechanisms and the identification of new therapeutic targets. This review provides a thorough examination of ALS, covering its epidemiology, pathology, and clinical features. It investigates the key molecular mechanisms, such as protein aggregation, neuroinflammation, oxidative stress, and excitotoxicity that contribute to motor neuron degeneration. The role of biomarkers is highlighted for their importance in early diagnosis and disease monitoring. Additionally, the review explores emerging therapeutic approaches, including inhibitors of protein aggregation, neuroinflammation modulators, antioxidant therapies, gene therapy, and stem cell-based treatments. The advantages and challenges of these strategies are discussed, with an emphasis on the potential for precision medicine to tailor treatments to individual patient needs. Overall, this review aims to provide a comprehensive overview of the current state of ALS research and suggest future directions for developing effective therapies.

Schlagwörter

Stichwörter der Autor:innen

amyotrophic lateral sclerosisdiagnosisneuroinflammationpathologytherapies

Autor:innen und Institutionen

  • Department of Agricultural Biotechnology, College of Agriculture and Food Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed-to-be-University), Bangalore 560027, India.
  • Department of Life Sciences, School of Sciences, Christ University, Bengaluru 560029, India.

Förderung

  • Deanship of Scientific Research, King Faisal University
  • King Faisal University

Zitieren

APA

Al-Khayri, J. M., Ravindran, M., Banadka, A., Vandana, C. D., Priya, K., Nagella, P., & Kukkemane, K. (2024). Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies. Pharmaceuticals, 17(10), 1391. https://doi.org/10.3390/ph17101391

Vancouver

Al-Khayri JM, Ravindran M, Banadka A, Vandana CD, Priya K, Nagella P, et al. Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies. Pharmaceuticals. 2024;17(10):1391. doi:10.3390/ph17101391

BibTeX
@article{AlKhayri2024,
  author = {Al-Khayri, Jameel M and Ravindran, Mamtha and Banadka, Akshatha and Vandana, Chendanda Devaiah and Priya, Kushalva and Nagella, Praveen and Kukkemane, Kowshik},
  title = {Amyotrophic Lateral Sclerosis: Insights and New Prospects in Disease Pathophysiology, Biomarkers and Therapies},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {10},
  pages = {1391},
  doi = {10.3390/ph17101391}
}
Kostenlos starten →